Completed NA INTERVENTIONAL 2-arm NCT02207101

Study to Assess the Effect of OXYJUN on Ejection Fraction and Markers of Cardiovascular Injury (Enduoxy)

The Effect of Investigational Product E-OJ-01 (OXYJUN) on Left Ventricular Ejection Fraction and Markers of Cardiovascular Injury.

Sponsor: Enovate Biolife Pvt Ltd

Conditions Cardiac Function in Young Athletes

Interventions E-OJ-01 (OXYJUN) Placebo

Updated 5 times since 2017 Last updated: Jul 9, 2015 Started: Dec 31, 2014 Primary completion: Jul 31, 2015 Completion: Jul 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Cardiac Function in Young Athletes, this trial is completed. The trial is conducted by Enovate Biolife Pvt Ltd and has accumulated 5 data snapshots since 2014. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Dec 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Enovate Biolife Pvt Ltd
Vedic Lifesciences Pvt. Ltd.

Data source: Vedic Lifesciences Pvt. Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mumbai, India